High failure rate of the ViroSeq HIV-1 genotyping system for drug resistance testing in Cameroon, a country with broad HIV-1 genetic diversity

Journal of Clinical Microbiology

Volumn 49, Issue 4, 2011, Pages 1635-1641

  Aghokeng, Avelin F ^a,b   Mpoudi Ngole, Eitel ^a   Chia, Julius E ^a   Edoul, Elvine M ^a   Delaporte, Eric ^b   Peeters, Martine ^a  

^a Institut de Recherche pour le Developpement Cameroon   (Cameroon)

^b UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;

ANALYTICAL EQUIPMENT; ANTIVIRAL RESISTANCE; ARTICLE; CAMEROON; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ALIGNMENT; VIRAL GENETICS; VIRUS CULTURE; VIRUS ISOLATION; VIRUS LOAD; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN;

CAMEROON; DRUG RESISTANCE, VIRAL; GENETIC VARIATION; GENOTYPE; HIV INFECTIONS; HIV-1; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MOLECULAR TYPING; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79953836237     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01478-10     Document Type: Article

References (14)

1. Bennett, D. E., M. Myatt, S. Bertagnolio, D. Sutherland, and C. F. Gilks. 2008. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir. Ther. 13(Suppl.)2: 25-36. (Pubitemid 352019087)
2. Bile, E. C., et al. 2005. Performance of drug-resistance genotypic assays among HIV-1 infected patients with predominantly CRF02-AG strains of HIV-1 in Abidjan, Cote d'Ivoire. J. Clin. Virol. 32:60-66. (Pubitemid 39575017)
3. Eshleman, S. H., et al. 2005. Sensitivity and specificity of the ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for detection of HIV-1 drug resistance mutations by use of an ABI PRISM 3100 genetic analyzer. J. Clin. Microbiol. 43:813-817. (Pubitemid 40256039)
4. Eshleman, S. H., et al. 2004. Performance of the Celera Diagnostics ViroSeq HIV-1 genotyping system for sequence-based analysis of diverse human immunodeficiency virus type 1 strains. J. Clin. Microbiol. 42:2711-2717. (Pubitemid 38747526)
5. The EuroGuidelines Group for HIV Resistance. 2001. Clinical and laboratory guidelines for the use of HIV-1 drug resistance testing as part of treatment management: Recommendations for the European setting. AIDS 15:309-320.
6. Grant, R. M., et al. 2003. Accuracy of the TRUGENE HIV-1 genotyping kit. J. Clin. Microbiol. 41:1586-1593. (Pubitemid 36428108)
7. Huang, D. D., S. H. Eshleman, D. J. Brambilla, P. E. Palumbo, and J. W. Bremer. 2003. Evaluation of the editing process in human immunodeficiency virus type 1 genotyping. J. Clin. Microbiol. 41:3265-3272. (Pubitemid 36842332)
8. Lole, K. S., et al. 1999. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 73:152-160. (Pubitemid 28565356)
9. Maes, B., et al. 2004. Performance of ViroSeq HIV-1 genotyping system in routine practice at a Belgian clinical laboratory. J. Virol. Methods 119:45-49. (Pubitemid 38510526)
10. Thompson, J. D., T. J. Gibson, F. Plewniak, F. Jeanmougin, and D. G. Higgins. 1997. The CLUSTAL-X windows interface: Flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res. 25:4876-4882. (Pubitemid 28022245)
11. Tong, C. Y., et al. 2005. Genotyping of B and non-B subtypes of human immunodeficiency virus type 1. J. Clin. Microbiol. 43:4623-4627. (Pubitemid 41298253)
12. Vergne, L., et al. 2000. Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: Evidence of many minor drug resistance mutations in treatmentnaive patients. J. Clin. Microbiol. 38:3919-3925. (Pubitemid 32233182)
13. Wallis, C. L., et al. 2010. Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1. J. Virol. Methods 163:505-508.
14. WHO. 2009. Rapid advice. Antiretroviral therapy for HIV infection in adults and adolescents. http://www.who.int/hiv/pub/arv/rapid-advice-art.pdf. Accessed 13 October 2010.